Gliclazide-d<sub>4</sub>

Gliclazide-d4

CAT N°: 33610
Price:

231.00 196.35

Gliclazide-d4 is intended for use as an internal standard for the quantification of gliclazide (Item No. 25503) by GC- or LC-MS. Gliclazide is a sulfonylurea and an inhibitor of pancreatic ?-cell ATP-sensitive potassium (KATP) channels (IC50 = 184 nM for murine ?-cells).{47058,34125} It is selective for pancreatic ?-cell over cardiac and arterial smooth muscle cell KATP channels (IC50s = 19.5 and 37.9 ?M, respectively).{47058} Gliclazide (5 ?M) increases insulin-induced glucose uptake and glucose transporter 4 (GLUT4) translocation to the plasma membrane in a differentiated 3T3L1 adipocyte model of insulin resistance induced by hydrogen peroxide.{47059} Gliclazide (5 and 10 ?g/ml) reduces LDL oxidation by human aortic smooth muscle cells (HASMCs), decreasing TBARS content and 8-isoprostane levels.{8975} It also decreases oxidized LDL-induced HASMC proliferation and monocyte adhesion when used at concentrations ranging from 1 to 10 ?g/ml. Gliclazide (5 mg/kg) reduces serum glucose levels and increases glucose uptake by isolated rat hindquarters in a model of diabetes induced by streptozotocin (STZ; Item No. 13104).{47060}

We also advise you